drugset / Trial / NCT03762382

Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring

NCT03762382

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of the study is to evaluate the safety, pharmacokinetics and pharmacodynamics of, and the tolerability and acceptance of an intravaginal ring (IVR) delivering both tenofovir and levonorgestrel (TFV/LNG) and an IVR delivering TFV only, compared to a placebo IVR, in women in Western Kenya.

Timeline

Start
2018-12-12
Primary completion
2019-08-20
Completion
2020-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 20 ug Other
Subject Tenofovir Small molecule 10 mg Other